4//SEC Filing
SANTARUS INC 4
Accession 0001209191-14-001563
CIK 0001172480operating
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 1:04 PM ET
Size
27.7 KB
Accession
0001209191-14-001563
Insider Transaction Report
Form 4
SANTARUS INCSNTS
CARTER MICHAEL G
Director
Transactions
- Disposition to Issuer
Stock Options (right to buy)
2014-01-02$29.00/sh−15,000$435,000→ 0 totalExercise: $3.00Exp: 2015-06-09→ Common Stock (15,000 underlying) - Disposition to Issuer
Stock Options (right to buy)
2014-01-02$25.27/sh−30,000$758,100→ 0 totalExercise: $6.73Exp: 2016-06-07→ Common Stock (30,000 underlying) - Disposition to Issuer
Stock Options (right to buy)
2014-01-02$10.07/sh−32,000$322,240→ 0 totalExercise: $21.93Exp: 2023-06-11→ Common Stock (32,000 underlying) - Disposition to Issuer
Stock Options (right to buy)
2014-01-02$24.85/sh−35,000$869,750→ 0 totalExercise: $7.15Exp: 2015-02-15→ Common Stock (35,000 underlying)
Footnotes (1)
- [F1]Represents options to purchase common stock of Santarus, Inc. ("Santarus"). In connection with the merger (the "Merger") of Willow Acquisition Sub Corporation ("Merger Sub") with and into Santarus pursuant to the Agreement and Plan of Merger, dated as of November 7, 2013 (the "Merger Agreement"), between Salix Pharmaceuticals, Ltd., Salix Pharmaceuticals, Inc., Merger Sub and Santarus, such options (i) became fully vested and exercisable prior to the effective time of the Merger and (ii) to the extent not exercised on or prior to the effective time, were cancelled and converted into the right to receive a cash payment in the amount by which the per share purchase price of $32.00 exceeded the exercise price of the option as of the effective time of the Merger.
Documents
Issuer
SANTARUS INC
CIK 0001172480
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001172480
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 1:04 PM ET
- Size
- 27.7 KB